DIANA BRIXNER
Professor
Pharmacotherapy
- ProfessorPharmacotherapy
- Adjunct ProfessorPediatrics
RESEARCH INTERESTS
- Design, conduct, and communication of pharmacoeconomic and outcomes research studies
GRANTS
- EXTERNAL GRANT OR CONTRACTTHE HEALTH RESOURCE UTILIZATION AND COSTS OF PATIENTS WITH MECHANICAL CHRONIC LOWER BACK PAIN1 Apr 2023 - 30 Jun 2024
- EXTERNAL GRANT OR CONTRACTREAL WORLD OUTCOMES AND HEALTH RESOURCE UTILIZATION FOR PATIENTS UTILIZING THE ENEURA SAVI (STMS) PRE AND POST DEVICE INITIATION26 Aug 2022 - 31 Dec 2024
- EXTERNAL GRANT OR CONTRACTREAL-WORLD OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS DIAGNOSED WITH OPIOID USE DISORDER (OUD) AND SUBSTANCE USE DISORDER (SUD)31 Jul 2022 - 31 Dec 2023
- EXTERNAL GRANT OR CONTRACTA REAL-WORLD EFFECTIVENESS STUDY THE IMPACT OF TOLVAPTAN VS A HISTORIC CONTROL ON PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)27 Apr 2022 - 27 Apr 2027
- EXTERNAL GRANT OR CONTRACTOTSUKA ADPKDOTSUKA AMERICA PHARMACEUTICAL1 Jan 2022 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTEVALUATION OF LOCALLY ADVANCED AND METASTATIC HER2-LOW BREAST CANCER ACROSS COMPREHENSIVE CANCER CENTERS: A DESCRIPTIVE STUDY1 May 2021 - 31 Dec 2025
- EXTERNAL GRANT OR CONTRACTIMPACT OF PHARMACOGENOMIC TESTING FOR VARIANTS OF DRUG METABOLIZING ENZYMES ON CLINICAL AND ECONOMIC OUTCOMES19 Mar 2021 - 31 Dec 2024
- EXTERNAL GRANT OR CONTRACTMERCK AZ PANCREATICMERCK SHARP & DOHME LLC6 Jan 2021 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTCANCER COST HRU IN IMMUNOCOMGRAIL INC1 Jan 2021 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTVALUE BASED FORMULARYPHARML RSRCH & MFGRS OF AMER F1 Jan 2021 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTHER-2 BREAST CANCERASTRAZENECA5 Nov 2020 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTPAREXEL LYMPHOMAPAREXEL INTERNATIONAL LLC9 Aug 2020 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTANALYSIS OF CLINICAL AND ECONOMIC OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME, A MULTISITE COHORT STUDY30 Jun 2020 - 31 Dec 2024
- EXTERNAL GRANT OR CONTRACTEXPLORATORY ANALYSIS OF PATIENT COUNTS IN INTERMEDIATE TO HIGH-RISK MYELODYSPLASTIC SYNDROME ACROSS ORIEN26 Nov 2019 - 31 Dec 2023
- EXTERNAL GRANT OR CONTRACTASSOCIATION OF CLINICAL CHARACTERISTICS AND GENETIC ALTERATIONS WITH NTRK FUSIONS1 Nov 2019 - 31 Dec 2023
- EXTERNAL GRANT OR CONTRACTAZ OSIMERTINIB SITE ANALYSISASTRAZENECA8 Aug 2019 - 31 Dec 2022
- EXTERNAL GRANT OR CONTRACTBMS SCCHNBRISTOL-MYERS SQUIBB6 May 2019 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTCOMPANION PROJECTBRISTOL-MYERS SQUIBB6 May 2019 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTSALIX OIC8 Jan 2019 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTALTERNATIVE PAYMENT MODELSCELGENE CORP1 Jan 2019 - 31 Dec 2021
- EXTERNAL GRANT OR CONTRACTPHARMACY EXTENSION SOLUTIONAMERISOURCEBERGEN1 Jan 2019 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTBMS TMB COST EFFECTIVENESSBRISTOL-MYERS SQUIBB5 Nov 2018 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTBMS HEAD AND NECK CANCERBRISTOL-MYERS SQUIBB1 Jan 2018 - 31 Dec 2020
- EXTERNAL GRANT OR CONTRACTORIEN FEASIBILITY FOR NSCLCASTRAZENECA1 Jan 2018 - 31 Dec 2019
- EXTERNAL GRANT OR CONTRACTSANOFI RHEUMATOID ARTHRITISSANOFI US SERVICES INC1 Jan 2018 - 11 Jul 2019